GL1X · GenesisL1 explorer

Research workbench

Crystal structure of uncleaved SARS-cov-2 main protease C145S mutant in complex with nirmatrelvir

Analyse Crystal structure of uncleaved SARS-cov-2 main protease C145S mutant in complex… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
8DG3
Type
protein
Length
606 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase NSP5
UniProt
P0DTD1
Ligands
4WI
Pockets
6 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B3C-like proteinase NSP5protein30326% helix, 29% strandP0DTD1

Ligands and binding sites

  • 4WI · (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19260.790.8180empty
25490.630.7577empty
32190.540.78274WI
42030.510.77294WI
51190.420.7627empty

Interfaces

1 interface between chains.

  • A–B · 1274 Ų buried · 22 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.